{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-006379","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.525046+00:00","generated_at":"2026-05-25T05:40:53.426454+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Richard Pilnik to retire from DiaMedica board at 2025 AGM","bullets":["Richard Pilnik, director for over 15 years, will retire and not stand for re-election at the 2025 AGM, effective May 15, 2025.","His decision is not due to any disagreement with the company on operations, policies, or practices.","Chairman role already transitioned to James Parsons; board also recently added Daniel O'Connor as new director.","Board to re-evaluate committee composition and chair roles after Pilnik's departure for seamless transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-006379","json":"https://secwatch.observer/filing/0001437749-25-006379.json","markdown":"https://secwatch.observer/filing/0001437749-25-006379.md","text":"https://secwatch.observer/filing/0001437749-25-006379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925006379/0001437749-25-006379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925006379/dmtp20250305_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T05:40:53.426454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b12be81d9","claim":"Richard Pilnik departed as Director at DiaMedica Therapeutics Inc..","evidence_excerpt":"On February 28, 2025, Richard Pilnik, who has been a member of the Board of Directors (the “Board”) of DiaMedica Therapeutics Inc. (the “Company”), for over 15 years, informed the Company of his decision to retire and not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925006379/0001437749-25-006379-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}